UBS Group »

Inozyme Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $197k 46k 4.26
2023-09-30 $80k 19k 4.20
2023-06-30 $120k 22k 5.57
2022-12-31 $3.0k 2.8k 1.05
2022-06-30 $1.0k 115 8.70
2022-03-31 $26k 6.3k 4.12
2021-12-31 $49k 7.2k 6.73
2021-06-30 $999 48 20.83
2021-03-31 $20k 1.0k 19.96
2020-09-30 $14k 536 26.12